| General Information of Drug Metabolite (DM) (ID: DM017812) |
| DM Name |
TAK-802 Metabolite M-II
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2B6 (CYP2B6)
|
DME0020
|
| Unclear - Unclear |
TAK-802
|
[1] |
|
Cytochrome P450 2E1 (CYP2E1)
|
DME0013
|
| Unclear - Unclear |
TAK-802
|
[1] |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
TAK-802
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| TAK-802 |
DR2997
|
Discontinued in Phase 2 |
Urinary dysfunction |
|
|
| References |
| 1 |
Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11-hydroxysteroid dehydrogenase 1
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
